We are live on ! Find out more
AGRX

Agile Therapeutics
AGRX

Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

1 hedge funds and large institutions have $596 invested in Agile Therapeutics in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

95% less funds holding

Funds holding: 21 → 1 (-20)

100% less capital invested

Capital invested by funds: $496K → $596 (-$496K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 20

Holders
1
Holders Change
-20
Holders Change %
-95.24%
% of All Funds
0.01%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
–
Increased
–
Reduced
–
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$211K
2
Renaissance Technologies
Renaissance Technologies
New York
-$115K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$39.9K
4
Citadel Advisors
Citadel Advisors
Florida
-$37.5K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$26.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
1
Investor AB
Sweden
$596 – – –
AC
2
Armistice Capital
New York
– -$211K -108,000 Closed
Renaissance Technologies
3
Renaissance Technologies
New York
– -$115K -59,200 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
– -$39.9K -20,477 Closed
Citadel Advisors
5
Citadel Advisors
Florida
– -$37.5K -19,247 Closed
Geode Capital Management
6
Geode Capital Management
Massachusetts
– -$26.8K -13,748 Closed
State Street
7
State Street
Massachusetts
– -$21.1K -10,843 Closed
JP Morgan Chase
8
JP Morgan Chase
New York
– -$15K -7,712 Closed
BlackRock
9
BlackRock
New York
– -$11.2K -5,745 Closed
TRCT
10
Tower Research Capital (TRC)
New York
– -$6.39K -3,276 Closed
ASN
11
Advisory Services Network
Georgia
– -$3.94K -2,020 Closed
UBS Group
12
UBS Group
Switzerland
– -$2.71K -1,387 Closed
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
– -$2K -798 Closed
Citigroup
14
Citigroup
New York
– -$353 -181 Closed
Morgan Stanley
15
Morgan Stanley
New York
– -$176 -90 Closed
Wells Fargo
16
Wells Fargo
California
– -$37 -19 Closed
CPG
17
Cornerstone Planning Group
New Jersey
– -$20 -10 Closed
Group One Trading
18
Group One Trading
Illinois
– -$20 -10 Closed
Comerica Bank
19
Comerica Bank
Texas
– -$8 -4 Closed
Osaic Holdings
20
Osaic Holdings
Arizona
– -$7 -4 Closed

AGRX Hedge Fund Activity: Q1 2024 in Review

1 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Agile Therapeutics (AGRX) for Q1 2024, worth a combined $596 — down 100% from $496K a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of AGRX and 0 opened new positions — a net loss of 20 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Armistice Capital, exiting entirely with an estimated $211K sold.

  • 1 institutional investor held Agile Therapeutics (AGRX) as of Q1 2024, down from 21 in Q4 2023.
  • Funds reported $596 of Agile Therapeutics stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Agile Therapeutics positions in Q1 2024 and 20 closed out, a net change of -20 holders.
  • The largest Agile Therapeutics seller in Q1 2024 was Armistice Capital, an estimated $211K sold.

Based on aggregated 13F filings for Q1 2024.